Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Buy" from Analysts

Retrieved on: 2020-12-30 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Buy" from Analysts. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,306,181 shares of the medical research company's stock worth $1,041,218,000 after acquiring an additional 292,900 ...

Article found on: www.marketbeat.com